|
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...."
|
5R01CA134458-04
|
$289,474
|
$289,474
|
SKORSKI, TOMASZ
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5R00CA134743-04
|
$245,188
|
$196,150
|
Feng, Hui
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
1R01CA180037-01
|
$325,948
|
$325,948
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
1st Annual Tandem ASPHO/PBMTC Educational Mtg: New Frontiers in Pediatric AlloSCT
|
1R13CA177155-01
|
$5,000
|
$5,000
|
Cairo, Mitchell
|
NEW YORK MEDICAL COLLEGE
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-02
|
$327,684
|
$163,842
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???
|
5R01CA158275-04
|
$294,525
|
$294,525
|
Crooks, Peter
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$425,790
|
$170,316
|
Rothman, Nat
|
DCEG (NCI)
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMA
|
ZIA CP010121-10363
|
$39,667
|
$39,667
|
Lan, Qing
|
DCEG (NCI)
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
1U01CA174844-01
|
$479,542
|
$479,542
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
$82,302
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel hematopoietic stem cell population
|
1F31CA180604-01
|
$45,637
|
$45,637
|
Balcerek, Joanna
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
5K08CA140720-04
|
$149,387
|
$149,387
|
Druley, Todd
|
WASHINGTON UNIVERSITY
|
|
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
|
5R44CA144362-03
|
$925,328
|
$231,332
|
Wiener, Matthew
|
PHARMATECH, INC.
|
|
A role for elevated autophagy in survival and chemoresistance of leukemia stem ce
|
5R21CA158728-02
|
$172,761
|
$172,761
|
Guzman, Monica
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$317,388
|
$31,739
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
5R01CA168900-02
|
$312,080
|
$156,040
|
Powell, Daniel
|
UNIVERSITY OF PENNSYLVANIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
7K08CA160660-03
|
$156,330
|
$156,330
|
Kentsis, Alex
|
SLOAN-KETTERING INST CAN RES
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$625
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$360,843
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$410,416
|
$205,208
|
Aplan, Peter
|
CCR (NCI)
|
|
Acute Myeloid Leukemia: MRD Analysis Using Modular uFluidics and uFlow Cytometry
|
1R21CA173279-01A1
|
$296,659
|
$296,659
|
Soper, Steven
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-05
|
$358,720
|
$179,360
|
Brentjens, Renier
|
SLOAN-KETTERING INST CAN RES
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
$3,217,256
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
|
1R01CA180175-01
|
$314,028
|
$314,028
|
Degregori, James
|
UNIVERSITY OF COLORADO DENVER
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119-10527
|
$507,725
|
$203,090
|
Alavanja, Michael
|
DCEG (NCI)
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
7R01CA139032-05
|
$296,649
|
$296,649
|
Muschen, Markus
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-08
|
$357,411
|
$357,411
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-03
|
$170,100
|
$170,100
|
Bleakley, Marie
|
FRED HUTCHINSON CAN RES CTR
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$60,238
|
$40,359
|
Kochenderfer, James
|
CCR (NCI)
|
|
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
|
7R01CA118116-06
|
$248,131
|
$248,131
|
Yu, Xue-Zhong
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Allosteric Inhibitor Discovery Technology for Protein Kinases
|
5R21CA169962-02
|
$187,379
|
$187,379
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
5R01CA170250-02
|
$553,060
|
$553,060
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Amplifying Radiation Potency Against Leukemic Stem Cells
|
5R21CA164098-02
|
$165,605
|
$165,605
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Analysis of higher order chromatin structures in normal and cancer epigenomes
|
5R01CA140485-04
|
$313,125
|
$313,125
|
Kim, Tae Hoon
|
YALE UNIVERSITY
|
|
Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia
|
4R00CA148963-02
|
$234,061
|
$234,061
|
Hyde, Ricia
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Analysis of the leukemic stem cell niche in chronic myeloid leukemia
|
5K08CA138916-04
|
$162,568
|
$162,568
|
Krause, Daniela
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,287,528
|
$64,376
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Angiocidin, a Novel Differentiation Agent for the Treatment of Leukemia
|
1R43CA173947-01A1
|
$288,301
|
$288,301
|
SWINDELL, CHARLES
|
DIFFREGEN, LLC
|
|
Animal models to study the role of INK4b loss in human acute myeloid leukemia
|
ZIA BC 011027
|
$347,100
|
$347,100
|
Wolff, Linda
|
CCR (NCI)
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-26
|
$296,510
|
$296,510
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-27
|
$350,629
|
$140,252
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Apoptosome Regulation in Leukemia by Protein Phosphatase 5 Hypoacetylation
|
1F31CA174243-01
|
$32,168
|
$32,168
|
FOSS, KRISTEN
|
DUKE UNIVERSITY
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
$110,303
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Arsenic Trioxide activated pathways in malignant cells
|
5R01CA121192-07
|
$250,308
|
$250,308
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Assays for Screening Histone Modifications in Cancer
|
5R01CA107106-08
|
$213,136
|
$213,136
|
FREITAS, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
|
1R01CA163653-01A1
|
$324,211
|
$324,211
|
KOPAN, RAPHAEL
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$36,212
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011413
|
$30,119
|
$7,530
|
Kochenderfer, James
|
CCR (NCI)
|
Total relevant funding to Leukemia for this search: $234,861,010
|